These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7558342)

  • 1. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.
    Fidel PL; Cutright JL; Sobel JD
    Infect Immun; 1995 Oct; 63(10):4191-4. PubMed ID: 7558342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
    Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
    Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida-specific antibodies during experimental vaginal candidiasis in mice.
    Wozniak KL; Wormley FL; Fidel PL
    Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Candida.
    Fidel PL
    Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of vaginal cell populations during experimental vaginal candidiasis.
    Fidel PL; Luo W; Steele C; Chabain J; Baker M; Wormley F
    Infect Immun; 1999 Jun; 67(6):3135-40. PubMed ID: 10338532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of Candida albicans by vaginal cells from naïve mice.
    Steele C; Ozenci H; Luo W; Scott M; Fidel PL
    Med Mycol; 1999 Aug; 37(4):251-9. PubMed ID: 10421860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery.
    Fidel PL; Wolf NA; KuKuruga MA
    Infect Immun; 1996 Sep; 64(9):3793-9. PubMed ID: 8751931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local production of chemokines during experimental vaginal candidiasis.
    Saavedra M; Taylor B; Lukacs N; Fidel PL
    Infect Immun; 1999 Nov; 67(11):5820-6. PubMed ID: 10531235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL; Sobel JD
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection.
    Wormley FL; Cutright J; Fidel PL
    Med Mycol; 2003 Oct; 41(5):401-9. PubMed ID: 14653516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes.
    Black CA; Eyers FM; Russell A; Dunkley ML; Clancy RL; Beagley KW
    J Reprod Immunol; 1999 Nov; 45(1):1-18. PubMed ID: 10660259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection.
    Kelly KA; Gray HL; Walker JC; Rank RG; Wormley FL; Fidel PL
    Infect Immun; 2001 May; 69(5):3451-4. PubMed ID: 11292774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models for candidiasis.
    Romani L
    Curr Protoc Immunol; 2001 May; Chapter 19():Unit 19.6. PubMed ID: 18432757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
    Wozniak KL; Palmer G; Kutner R; Fidel PL
    Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal candidiasis: review and role of local mucosal immunity.
    Fidel PL
    AIDS Patient Care STDS; 1998 May; 12(5):359-66. PubMed ID: 11361971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.